Crohn disease Trials in Toruń, Poland
Conditions / Crohn disease / Toruń, Poland
Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02394028 | A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT05668013 | A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05499130 | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | COMPLETED | PHASE2 |
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE2/PHASE3 |
| NCT03440372 | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT05197049 | A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06257706 | VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease | RECRUITING | PHASE4 |
| NCT03467958 | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03464097 | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT05092269 | A Long-term Extension Study of Ustekinumab in Pediatric Participants | RECRUITING | PHASE3 |